ACCESSION: MSBNK-SMB_Measured-HSA001P0142017
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.14, Processed 2025.02.21, Annotated 2025.04.02, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 66
COMMENT: RAW_SPEC {'14_posi_17368': {'bp': 2285022.0, 'sum': 7033638.0}, '3_posi_17285': {'bp': 1965337.0, 'sum': 5958712.0}, '2_posi_17327': {'bp': 2055622.0, 'sum': 6188344.0}, '7_posi_17326': {'bp': 2094396.0, 'sum': 6400928.0}, '12_posi_17410': {'bp': 2112410.0, 'sum': 6347060.0}, '12_posi_17285': {'bp': 2144820.0, 'sum': 6477878.0}, '14_posi_17305': {'bp': 2171155.0, 'sum': 6593331.0}, '8_posi_17305': {'bp': 2172620.0, 'sum': 6444818.0}, '16_posi_17410': {'bp': 2176496.0, 'sum': 6582090.0}, '9_posi_17347': {'bp': 2178930.0, 'sum': 6568281.0}, '19_posi_17389': {'bp': 1867588.0, 'sum': 5634535.0}, '19_posi_17263': {'bp': 1922764.0, 'sum': 5799975.0}, '8_posi_17431': {'bp': 1937718.0, 'sum': 5918289.0}, '9_posi_17411': {'bp': 2071541.0, 'sum': 6276772.0}, '4_posi_17264': {'bp': 2074286.0, 'sum': 6282325.0}, '14_posi_17431': {'bp': 2092828.0, 'sum': 6325116.0}, '18_posi_17326': {'bp': 1854194.0, 'sum': 5620742.0}, '1_posi_17327': {'bp': 1934631.0, 'sum': 5906384.0}, '10_posi_17431': {'bp': 1947622.0, 'sum': 5909129.0}, '3_posi_17411': {'bp': 1979606.0, 'sum': 6079718.0}, '15_posi_17410': {'bp': 2037834.0, 'sum': 6163956.0}, '2_posi_17264': {'bp': 2039624.0, 'sum': 6284635.0}, '8_posi_17368': {'bp': 2079850.0, 'sum': 6365936.0}, '6_posi_17347': {'bp': 2106830.0, 'sum': 6351598.0}, '6_posi_17410': {'bp': 2143650.0, 'sum': 6552832.0}, '11_posi_17348': {'bp': 2183670.0, 'sum': 6657760.0}, '6_posi_17284': {'bp': 2192276.0, 'sum': 6704795.0}, '13_posi_17284': {'bp': 2149868.0, 'sum': 6494349.0}, '9_posi_17284': {'bp': 2213410.0, 'sum': 6759074.0}, '18_posi_17263': {'bp': 2049029.0, 'sum': 6172310.0}, '7_posi_17389': {'bp': 2073220.0, 'sum': 6346082.0}, '13_posi_17410': {'bp': 2209706.0, 'sum': 6701282.0}, '7_posi_17263': {'bp': 2243773.0, 'sum': 6838002.0}, '3_posi_17348': {'bp': 2117138.0, 'sum': 6480002.0}, '11_posi_17411': {'bp': 2163329.0, 'sum': 6558087.0}, '11_posi_17284': {'bp': 2176662.0, 'sum': 6587753.0}, '16_posi_17347': {'bp': 2181389.0, 'sum': 6578167.0}, '19_posi_17326': {'bp': 1982308.0, 'sum': 6079613.0}, '10_posi_17306': {'bp': 2264182.0, 'sum': 6777924.0}, '5_posi_17285': {'bp': 2065396.0, 'sum': 6379119.0}, '15_posi_17347': {'bp': 2054267.0, 'sum': 6202333.0}, '4_posi_17327': {'bp': 2044848.0, 'sum': 6228673.0}, '5_posi_17348': {'bp': 2042080.0, 'sum': 6218927.0}, '2_posi_17390': {'bp': 2028323.0, 'sum': 6206414.0}, 'BLK02_17328': {'bp': 1872100.0, 'sum': 5859539.0}, 'BLK02_17391': {'bp': 1758639.0, 'sum': 5516146.0}, '13_posi_17347': {'bp': 2179230.0, 'sum': 6616209.0}, '10_posi_17369': {'bp': 2147634.0, 'sum': 6496974.0}, '17_posi_17431': {'bp': 2086599.0, 'sum': 6358085.0}, 'ProcedureBlank_17284': {'bp': 2055306.0, 'sum': 6320303.0}, 'ProcedureBlank_17347': {'bp': 2011048.0, 'sum': 6271335.0}, '1_posi_17390': {'bp': 1969191.0, 'sum': 6100410.0}, '17_posi_17368': {'bp': 1957683.0, 'sum': 5899820.0}, 'ProcedureBlank_17410': {'bp': 1904436.0, 'sum': 5773329.0}, '15_posi_17284': {'bp': 2134169.0, 'sum': 6454043.0}, '17_posi_17305': {'bp': 2116462.0, 'sum': 6557518.0}, '5_posi_17411': {'bp': 2095904.0, 'sum': 6458904.0}, '18_posi_17389': {'bp': 1891087.0, 'sum': 5801140.0}, 'BLK02_17265': {'bp': 1864562.0, 'sum': 5768617.0}, 'BLK01_17452': {'bp': 1819995.0, 'sum': 5920021.0}, '12_posi_17347': {'bp': 2042529.0, 'sum': 6256959.0}, '4_posi_17390': {'bp': 2019721.0, 'sum': 6152678.0}, '1_posi_17264': {'bp': 1913690.0, 'sum': 5874190.0}, 'BLK01_17389': {'bp': 1794600.0, 'sum': 5705360.0}, '16_posi_17284': {'bp': 2275383.0, 'sum': 6853365.0}, 'BLK01_17326': {'bp': 1718096.0, 'sum': 5475181.0}}
COMMENT: RETENTION_TIME_STDEV 0.108
COMMENT: PRECURSOR_M/Z_RAW 142.097198
COMMENT: PRECURSOR_M/Z_STDEV 0.000041
COMMENT: PRECURSOR_IN_MS1 ND
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.369; C6H11N3O; [M+H]+; delta(ppm) 0.368558
COMMENT: PROPOSED_MF MS-FINDER 3.765; C6H11N3O; [M+H]+; delta(ppm) 0.362941
COMMENT: PROPOSED_MF SIRIUS5_Sirius 25.301; C6H11N3O; [M+H]+; delta(ppm) 0.362941
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C6H11N3O; [M+H]+; delta(ppm) 0.362941
COMMENT: PROPOSED_MF SIRIUS6_Sirius 32.446; C6H11N3O; [M+H]+; delta(ppm) 0.362941
COMMENT: PROPOSED_MF SIRIUS6_Sirius 11.786; C4H9N6; [M+H]+; delta(ppm) 9.811924
COMMENT: PROPOSED_MF SIRIUS6_Sirius 6.590; C8H13O2; [M+H]+; delta(ppm) -9.085864
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C6H11N3O; [M+H]+; delta(ppm) 0.362941
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.821; ZQISRDCJNBUVMM-YFKPBYRVSA-N; [M+H]+; N[C@H](CO)CC1=CN=CN1
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.201; ZQISRDCJNBUVMM-YFKPBYRVSA-N; [M+H]+; L-Histidinol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; ZQISRDCJNBUVMM-YFKPBYRVSA-N; [M+H]+; L-Histidinol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.617; ZQISRDCJNBUVMM-YFKPBYRVSA-N; [M+H]+; (2S)-2-amino-3-(1H-imidazol-5-yl)propan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.200; OCEJLBIKKZYCBH-UHFFFAOYSA-N; [M+H]+; 1-(azetidin-3-yl)imidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.183; WRNALNJFNAAVKM-UHFFFAOYSA-N; [M+H]+; 2,5,7-triazaspiro[3.5]nonan-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.140; QJCMYUTUCCCBMY-UHFFFAOYSA-N; [M+H]+; 1-(3-aminopyrazol-1-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.136; ZQIOGDSNYJYBTN-UHFFFAOYSA-N; [M+H]+; 3-(3-aminopyrazol-1-yl)propan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.120; LGPFTDILVKZMRC-UHFFFAOYSA-N; [M+H]+; 2-(3-amino-4-methylpyrazol-1-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.092; RTGLANPQFMENLF-UHFFFAOYSA-N; [M+H]+; 2,5,6,7,8,8a-hexahydro-1H-imidazo[1,5-a]pyrazin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.090; RYFSOJLJCKEYBP-UHFFFAOYSA-N; [M+H]+; 3-(1-aminoethyl)-1-methylpyrazol-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.084; YUTDFIMDLUJOJK-UHFFFAOYSA-N; [M+H]+; N-methyl-1,6-diazabicyclo[3.1.0]hexane-5-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.063; YCXQDZIPLMEYGK-UHFFFAOYSA-N; [M+H]+; 2-[4-(methylamino)pyrazol-1-yl]ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.062; OZGHNDLEHPCVJQ-UHFFFAOYSA-N; [M+H]+; 2-[4-(aminomethyl)pyrazol-1-yl]ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.059; IUBWCBLFKCGVGV-UHFFFAOYSA-N; [M+H]+; 2-(2-iminopyrrolidin-1-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.053; ASEMWMLOGSUFFL-UHFFFAOYSA-N; [M+H]+; 4-(2-aminoethyl)-3-methyl-1,4-dihydropyrazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.051; NMGPZPUIAUQPJA-UHFFFAOYSA-N; [M+H]+; [1-(2-aminoethyl)imidazol-4-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.047; VCSSOKBEBXXSDV-UHFFFAOYSA-N; [M+H]+; 5-methyl-2,5,7-triazaspiro[3.4]octan-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.038; VWUSXTIUSAVEAQ-UHFFFAOYSA-N; [M+H]+; (1-propan-2-yltriazol-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.035; AJOFBNLXIBLIPM-UHFFFAOYSA-N; [M+H]+; 2-amino-1-(1-methylimidazol-2-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.035; ITDOBWWRWYKLQJ-UHFFFAOYSA-N; [M+H]+; 2,3,4,5-tetrahydropyridin-6-ylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.034; QKHNQZUVFSQKFD-UHFFFAOYSA-N; [M+H]+; 2-amino-1-(1-methylpyrazol-4-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.032; OZVXTNDTEWDMGH-UHFFFAOYSA-N; [M+H]+; 2-amino-2-(1-methylpyrazol-4-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.031; VCPRZYKEIPMTGJ-UHFFFAOYSA-N; [M+H]+; 2-amino-2-(1-methylpyrazol-3-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.030; XIAOMTCYUPNRKB-UHFFFAOYSA-N; [M+H]+; (2-propan-2-yl-1,2,4-triazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.022; ANQYOZSPKNDFPD-UHFFFAOYSA-N; [M+H]+; 2-(5-amino-3-methylpyrazol-1-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.016; GTEXXCCAHDQARI-UHFFFAOYSA-N; [M+H]+; 1-amino-3-pyrazol-1-ylpropan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.016; IZYJJPFDVHGKAG-UHFFFAOYSA-N; [M+H]+; 2-(1-methyltriazol-4-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.015; SRIBOFCAJXTSEL-UHFFFAOYSA-N; [M+H]+; 1-(1-methyltriazol-4-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.005; LEWKFFUYRKWKLV-UHFFFAOYSA-N; [M+H]+; 5-methyl-2-propan-2-yl-4H-1,2,4-triazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.005; HKUSMMLJSPSXCL-UHFFFAOYSA-N; [M+H]+; 5-(3-aminopropyl)-1,2-dihydropyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.999; ZPUGMHPXVOHOAZ-UHFFFAOYSA-N; [M+H]+; (4-propyl-1,2,4-triazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.994; IPLIJMUJLJBZDZ-UHFFFAOYSA-N; [M+H]+; 1-amino-3-imidazol-1-ylpropan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.958; VPOYXTRLFXNRJN-UHFFFAOYSA-N; [M+H]+; N-methyl-3-propan-2-yl-1,2,4-oxadiazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.957; LHHBJUDYVRBYMB-UHFFFAOYSA-N; [M+H]+; 4-(aminomethyl)-2,5-dimethyl-1H-pyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.939; JANUDBLANRHSLI-UHFFFAOYSA-N; [M+H]+; 5-butyl-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.932; BMHYWTFRHPIOQM-UHFFFAOYSA-N; [M+H]+; 2-(2-oxopyrrolidin-1-yl)ethanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.858; BIJFXVFSSOVINP-UHFFFAOYSA-N; [M+H]+; 1-(5-ethyl-1,2,4-oxadiazol-3-yl)-N-methylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.849; WBHVOQXHRCGQTP-UHFFFAOYSA-N; [M+H]+; 1-(3-ethyl-1,2,4-oxadiazol-5-yl)-N-methylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.803; REYGCAPKUGCICS-UHFFFAOYSA-N; [M+H]+; N-[(3-methyl-1,2,4-oxadiazol-5-yl)methyl]ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.787; KENWBTPXOITUBG-UHFFFAOYSA-N; [M+H]+; 3-(5-methyl-1,3,4-oxadiazol-2-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.786; QOGFVKATFSDNGB-UHFFFAOYSA-N; [M+H]+; 2-(5-methyl-1,2,4-oxadiazol-3-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.784; AEBOLOPWWMZLBL-UHFFFAOYSA-N; [M+H]+; 2-(3-methyl-1,2,4-oxadiazol-5-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.783; PEPBWGGISBCQDW-UHFFFAOYSA-N; [M+H]+; (3-propan-2-yl-1,2,4-oxadiazol-5-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.779; XGPRUICIGLRGSQ-UHFFFAOYSA-N; [M+H]+; (5-propan-2-yl-1,2,4-oxadiazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.769; WWGWIEDOVSRZPU-UHFFFAOYSA-N; [M+H]+; 2-tert-butyl-4H-1,2,4-triazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.721; VUQAASCCQZTWOG-UHFFFAOYSA-N; [M+H]+; 5-butan-2-yl-1,2,4-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.720; CIZWSGSWDKEWQD-UHFFFAOYSA-N; [M+H]+; 1-(2-methoxyethyl)pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.719; QYLRWTDPRQLHNV-UHFFFAOYSA-N; [M+H]+; 2-(3-methyldiazirin-3-yl)morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.668; VQNRBFXKOWOEAC-UHFFFAOYSA-N; [M+H]+; 3-ethoxy-1-methylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.667; XWBPAFFFOLTPTR-UHFFFAOYSA-N; [M+H]+; 3-(methoxymethyl)-1-methylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.663; KGTZRGLLNSCJNH-UHFFFAOYSA-N; [M+H]+; 5-(2-methylpropyl)-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.660; KJTMKVRSTYLHQN-UHFFFAOYSA-N; [M+H]+; 5-(methoxymethyl)-1-methylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.660; KJASFPYFMYPMHS-UHFFFAOYSA-N; [M+H]+; 5-(methoxymethyl)-2-methylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.652; YGJWTXRSKNXUAY-UHFFFAOYSA-N; [M+H]+; 5-methoxy-1,3-dimethylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.636; LURMHCWOXHNATM-UHFFFAOYSA-N; [M+H]+; 1-(2-methoxyethyl)pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.633; UXZYNPKVFMWVMT-UHFFFAOYSA-N; [M+H]+; 1-ethyl-3-methoxypyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.624; OANNGOSSNLIIIV-UHFFFAOYSA-N; [M+H]+; 3-methoxy-1,5-dimethylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.604; YEKKCMQUYOKDQD-UHFFFAOYSA-N; [M+H]+; 3-(3-methyl-1,2,4-oxadiazol-5-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.597; MGDACALOFCAYGF-UHFFFAOYSA-N; [M+H]+; (3-methoxy-1-methylpyrazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.538; ILUUSWWGUOPVLO-UHFFFAOYSA-N; [M+H]+; 3-tert-butyl-1,2,4-oxadiazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.538; VAYGOKAONCMZCM-UHFFFAOYSA-N; [M+H]+; 5-tert-butyl-1,2,4-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.520; WONCYNYJYMAVNA-UHFFFAOYSA-N; [M+H]+; 5-tert-butyl-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -196.911; ITDOBWWRWYKLQJ; [M+H]+; (2-Piperidylidene)urea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -205.300; YDDAGKSURVEMCI; [M+H]+; Acetamide, 2-diazo-N,N-diethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -232.839; UEUMMYRZUZKMRI; [M+H]+; Ambap52883-26-8
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -247.409; KENWBTPXOITUBG; [M+H]+; [3-(5-methyl-1,3,4-oxadiazol-2-yl)propyl]amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -252.995; YUTDFIMDLUJOJK; [M+H]+; N-methyl-1,6-diazabicyclo[3.1.0]hexane-5-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -257.779; WONCYNYJYMAVNA; [M+H]+; 2-Amino-5-tert-butyl-1,3,4-oxadiazol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -291.623; QIXFXNMDRJRTIJ; [M+H]+; 1-Hem-aminoimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -292.082; DUCOZVHXTHIRIB; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -298.456; ZQISRDCJNBUVMM; [M+H]+; histidol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -308.391; CIZWSGSWDKEWQD; [M+H]+; 1-(2-methoxyethyl)-1H-pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -315.909; LURMHCWOXHNATM; [M+H]+; 1-(2-methoxyethyl)pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -338.423; IPLIJMUJLJBZDZ; [M+H]+; 3-amino-1-imidazolylpropan-2-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.239; ITDOBWWRWYKLQJ; [M+H]+; (2-Piperidylidene)urea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -98.574; IBDALCUMPRWSHZ; [M+H]+; 3,5,6-trimethyl-2H-1,3,5-triazin-4-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -106.804; AXFSOKJHIFZWIG; [M+H]+; N'-[1-(methoxymethylamino)ethenyl]-N-methylidenemethanimidamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -111.540; WKPMFEMKRZWUNR; [M+H]+; 1,3-Dimethylcytosine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -113.842; PBFPAJJYZXAJBF; [M+H]+; (NZ)-N-[(1,3-dimethyl-2H-imidazol-2-yl)methylidene]hydroxylamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -118.650; LHEGAVDEJHZSGL; [M+H]+; N,N-dimethyl-3-oxido-2H-pyrimidin-3-ium-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -119.501; XAJSQVLZZMKQIN; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -120.502; COULCWXFKZLLED; [M+H]+; 1-(Cyanomethyl)-1,3,3-trimethylurea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -120.630; BVDGHNOVVQEIHS; [M+H]+; 1-Ethyl-3-[1-(methylideneamino)ethylidene]urea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -122.477; KTMUAYRSYVWTGE; [M+H]+; 3-Methyl-6-(methylamino)-1,4-dihydropyrimidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -123.349; HRAOLRUNDASOAP; [M+H]+; N'-(cyanomethoxy)-N,N-dimethylethanimidamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.158; IBDALCUMPRWSHZ; [M+H]+; 3,5,6-trimethyl-2H-1,3,5-triazin-4-one
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C6H12N3O1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 34.821
MS$FOCUSED_ION: PRECURSOR_M/Z 142.097540
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-00dl-9700000000-9fb9d26e2d9ccd835f86
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  60.0444507 3.0451 60.045090 1.3157 0.84 -0.2246 62 f{C2H6N1O1}/1.01ppm,p-C4H6N2
  69.0447344 3.0817 69.045360 1.5063 0.73 -0.0062 63 f{C3H5N2}/0.14ppm,p-C3H7N1O1
  70.0651505 6.0888 70.065770 1.0276 1.12 0.1244 66 f{C4H8N1}/0.35ppm,p-C2H4N2O1
  71.0603868 995.5961 71.061000 0.2674 14.98 0.9174 66 f{C3H7N2}/0.17ppm,p-C3H5N1O1
  72.0443735 538.5806 72.044980 0.3192 12.06 0.8725 66 f{C3H6N1O1}/-0.23ppm,p-C3H6N2
  73.0760109 7.7705 73.076610 0.9305 1.51 -0.0143 66 f{C3H9N2}/-0.19ppm,p-C3H3N1O1
  83.0603863 4.7381 83.060890 1.3123 1.22 -0.0761 66 f{C4H7N2}/0.14ppm,p-C2H5N1O1
  84.0681683 3.4188 84.068660 1.2847 0.90 0.2501 58 f{C4H8N2}/-0.37ppm,p-C2H4N1O1
  85.0759958 4.6872 85.076475 1.3870 1.15 0.1793 66 f{C4H9N2}/-0.34ppm,p-C2H3N1O1
  87.0552664 2.5407 87.055720 1.8264 0.65 -0.1265 47 f{C3H7N2O1}/-0.26ppm,p-C3H5N1
  97.0760450 27.4926 97.076390 0.6078 2.88 0.2763 66 f{C5H9N2}/0.21ppm,p-C1H3N1O1
  99.0552656 10.2633 99.055595 1.3528 1.57 0.2865 66 f{C4H7N2O1}/-0.24ppm,p-C2H5N1
  100.0869290 3.9259 100.087250 1.5187 1.23 0.2574 66 f{C4H10N3}/0.05ppm,p-C2H2O1
  101.0709423 21.0822 101.071255 0.8014 2.93 0.0527 66 f{C4H9N2O1}/0.03ppm,p-C2H3N1
  113.0709664 4.1859 113.071160 1.5654 1.15 0.1490 66 f{C5H9N2O1}/0.24ppm,p-C1H3N1
  113.0903516 4.0399 113.090545 1.5474 1.20 -0.1310 64 ?
  114.0662077 7.6613 114.066390 1.3150 1.43 -0.2033 66 f{C4H8N3O1}/0.17ppm,p-C2H4
  114.1026582 10.0747 114.102840 1.0429 1.73 -0.1120 66 f{C5H12N3}/0.74ppm,p-C1O1
  124.0869449 174.3721 124.087000 0.3062 23.81 0.4269 66 f{C6H10N3}/0.17ppm,p-H2O1
  125.0709386 190.1679 125.070980 0.2718 19.52 0.1398 66 f{C6H9N2O1}/-0.01ppm,p-H3N1
  142.0974971 999.0000 142.097400 0.2674 10.42 1.0000 66 f{C6H12N3O1}/0.06ppm,p
PK$NUM_PEAK: 21
PK$PEAK: m/z int. rel.int.
  60.044451 3.05 3
  69.044734 3.08 3
  70.065150 6.09 6
  71.060387 995.60 995
  72.044373 538.58 538
  73.076011 7.77 7
  83.060386 4.74 4
  84.068168 3.42 3
  85.075996 4.69 4
  87.055266 2.54 2
  97.076045 27.49 27
  99.055266 10.26 10
  100.086929 3.93 3
  101.070942 21.08 21
  113.070966 4.19 4
  113.090352 4.04 4
  114.066208 7.66 7
  114.102658 10.07 10
  124.086945 174.37 174
  125.070939 190.17 190
  142.097497 999.00 999
//
